Guangxi Boke Pharmaceutical

Guangxi Houde Pharmaceutical, formerly known as Guangxi Boke Pharmaceutical, is a Chinese pharmaceutical company founded in 1995 and based in Nanning. The company specializes in the development, manufacturing, and commercialization of plant-based traditional Chinese medicines (TCM), chemical drugs, and personal care products. Its core product portfolio includes treatments for nasal congestion (Ditong Biyan Shui), anti-dandruff medical shampoos (Compound Ketoconazole Shampoo), and various throat lozenges and analgesics. Acquired by American Oriental Bioengineering in 2007 and later rebranded in 2022, the company operates a GMP-certified facility and maintains an extensive distribution network across China. The firm continues to expand its portfolio into cardiovascular and neurological areas, including research into refined levodopa for Parkinson's disease.